Evidence map›Paper›PMID 35304252›Full record

ArticleThe Journal of investigative dermatology2022

Tumor Clone Frequency Calculation Using High-Throughput Sequencing of the TCRβ Gene in Patients with Folliculotropic Mycosis Fungoides.

Suzanne van Santen, Willem H Zoutman, Adèle de Masson, Koen D Quint, Rein Willemze, Nega Gerard, Jessica E Teague, Thomas S Kupper, Rachael A Clark, Cornelis P Tensen and 1 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Suzanne van SantenDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: s.van_santen@lumc.nl.
Willem H ZoutmanDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Adèle de MassonDepartment of Dermatology, INSERM U976, Saint-Louis Hospital, University of Paris, Paris, France.
Koen D QuintDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Rein WillemzeDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Nega GerardDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cutaneous (Skin) Cancer Treatment Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Jessica E TeagueDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cutaneous (Skin) Cancer Treatment Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Thomas S KupperDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cutaneous (Skin) Cancer Treatment Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Rachael A ClarkDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cutaneous (Skin) Cancer Treatment Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Cornelis P TensenDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Maarten H VermeerDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NLBrigham and Women's Hospital · USInserm · FR

Funding

Skin Homing T CellsR01AR065807 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUPPER, THOMAS S. · 2013 to 2022
$6.3M
Transforming the diagnosis and care of patients with CTCL using TCR sequencingR01CA203721 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN, KUPPER, THOMAS S. · 2016 to 2020
$3.4M
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphomaU01CA253190 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2020 to 2024
$2.1M
Reversing immune evasion and enhancing immune detection with topical resiquimodR01AR074797 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN, ROOK, ALAIN H · 2018 to 2021
$1.9M
NCI NIH HHS R01 CA203721NCI NIH HHS U01 CA253190NIAMS NIH HHS R01 AR065807NIAMS NIH HHS R01 AR074797
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycosis FungoidesSkin NeoplasmsClone CellsHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID35304252
PMCPMC11167127
OpenAlexW4220667307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.